Sleep Disturbances Limit 48-Hour ABPM Completion in Hemodialysis
For patients undergoing hemodialysis, monitoring blood pressure is a critical component of care. However, a recent international study published in the Journal of Hypertension highlights a significant hurdle in clinical practice: the difficulty many patients face when attempting 48-hour ambulatory blood pressure monitoring (ABPM).
The Challenge of Sustained Monitoring
Researchers evaluated 440 adult hemodialysis patients across eight nephrology units in three European countries to determine the feasibility of 48-hour ABPM. While 321 patients initially agreed to participate, only 257—or 58%—were able to successfully complete the protocol, which requires at least 44 hours of data and a 70% measurement completion rate.

The primary barriers to completion were largely rooted in patient discomfort. Nearly one-third of participants reported frequent sleep interruptions due to noise or physical discomfort. Other common complaints included itching (24%), pain during blood pressure measurements (20%), and difficulty falling or staying asleep.
Clinical Implications and Sleep Quality
The study utilized several standardized tools, including the Epworth sleepiness scale and the LEEDS sleep evaluation questionnaire, to assess the impact of the monitoring device on patient rest. The findings revealed that the physical requirements of the 48-hour ABPM process contributed to a worse quality of sleep compared to the night preceding the test.

there was a direct link between physical discomfort—specifically the inability to sleep and persistent pain during the procedure—and a patient’s dipping status. This suggests that the very tools used to track cardiovascular health may, for some, interfere with the physiological patterns they are intended to measure.
Looking Ahead: Bridging the Gap
Because the study was conducted at specialized centres with a focus on hypertension and ABPM, these results may not fully represent the experiences of hemodialysis patients in all clinical settings. As the medical community looks to integrate these monitoring protocols more broadly, future efforts may prioritize technical advancements alongside a deeper understanding of the patient’s lived experience.
A possible next step involves the development of more comfortable, less intrusive monitoring technology. By addressing the physical pain and sleep disturbances reported in this survey, clinicians could potentially improve compliance rates and ensure that the data gathered is both accurate and reflective of a patient’s true health status.
Frequently Asked Questions
Why is 48-hour ABPM difficult for hemodialysis patients to complete?
Many patients struggle to complete the protocol due to low tolerability. Common issues include frequent sleep interruptions, itching, pain during blood pressure cuff inflations, and an overall inability to sleep comfortably while wearing the device.

How does the monitoring process affect sleep quality?
Data from the LEEDS questionnaire indicated that patients experienced more difficulty falling asleep and poorer sleep quality during the 48-hour monitoring period compared to the night before the procedure began.
What is the significance of the “nondipper” status found in the study?
Nearly half of the patients who completed the study were classified as nondippers, meaning their blood pressure did not drop significantly at night. The study found that this status was associated with the reported inability to sleep and continuous pain during the monitoring procedure.
How might clinical practices evolve to better balance the need for accurate diagnostic data with the comfort of the patient?